Profile data is unavailable for this security.
About the company
Zivo Bioscience, Inc. is a research and development company. The Company operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its product candidates are at different stages of development for different applications. It is developing a product candidate targeting poultry gut health. It is developing products for Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Algal biomass for human consumption, and Biomass for supporting skin health/anti-aging. It is focused on licensing and selling natural bioactive ingredients derived from their proprietary algae cultures to animal, human and dietary supplement, and medical food manufacturers.
- Revenue in USD (TTM)27.65k
- Net income in USD-7.78m
- Incorporated1983
- Employees8.00
- LocationZivo Bioscience Inc21 E. Long Lake Road, Suite 100BLOOMFIELD HILLS 48304United StatesUSA
- Phone+1 (248) 452-9866
- Websitehttps://zivobioscience.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GlycoMimetics Inc | 10.00k | -36.90m | 19.68m | 35.00 | -- | 0.5119 | -- | 1,968.32 | -0.5841 | -0.5841 | 0.0002 | 0.5966 | 0.0002 | -- | 0.0625 | 285.71 | -75.98 | -43.60 | -90.65 | -47.82 | -- | -- | -368,994.20 | -2,243.52 | -- | -- | 0.00 | -- | -86.67 | -- | 20.97 | -- | -29.82 | -- |
| NanoViricides Inc | 0.00 | -9.36m | 19.79m | 7.00 | -- | 1.71 | -- | -- | -0.8004 | -0.8004 | 0.00 | 0.9828 | 0.00 | -- | -- | 0.00 | -55.47 | -43.54 | -57.90 | -46.29 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -5.94 | -- | -8.90 | -- |
| Evaxion Biotech A/S - ADR | 73.00k | -22.13m | 20.39m | 49.00 | -- | -- | -- | 279.33 | -81.29 | -81.29 | 0.2665 | -1.25 | 0.0042 | -- | 0.091 | 1,489.80 | -126.74 | -100.11 | -183.85 | -131.65 | -- | -- | -30,308.22 | -131,560.30 | -- | -30.92 | 1.77 | -- | -- | -- | 4.51 | -- | 65.53 | -- |
| Alaunos Therapeutics Inc | 5.00k | -35.14m | 20.82m | 1.00 | -- | 3.30 | -- | 4,163.25 | -2.20 | -2.20 | 0.0003 | 0.3939 | 0.0001 | -- | 2.00 | 5,000.00 | -96.01 | -74.83 | -149.28 | -89.57 | -- | -- | -702,800.00 | -10,508.06 | -- | -14.83 | 0.00 | -- | -99.83 | -49.08 | 6.86 | -- | -15.56 | -- |
| Eom Pharmaceutical Holdings Inc | 0.00 | -4.93m | 20.84m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
| MEI Pharma Inc | 72.65m | 19.84m | 20.85m | 46.00 | 1.05 | 0.3506 | 1.03 | 0.2871 | 2.98 | 2.98 | 10.90 | 8.93 | 0.6425 | -- | 25.47 | 1,579,304.00 | 17.55 | -25.31 | 20.31 | -28.59 | -- | -- | 27.32 | -122.05 | -- | -- | 0.00 | -- | 19.95 | 97.56 | 41.53 | -- | -- | -- |
| Sol Gel Technologies Ltd | 1.55m | -27.24m | 20.89m | 36.00 | -- | 0.5407 | -- | 13.44 | -1.02 | -1.02 | 0.0574 | 1.39 | 0.0338 | -- | 0.3774 | 43,166.67 | -59.27 | -31.60 | -64.80 | -35.49 | -- | -- | -1,752.77 | -135.76 | -- | -- | 0.00 | -- | -59.98 | 64.50 | -82.52 | -- | -33.78 | -- |
| Zivo Bioscience Inc | 27.65k | -7.78m | 21.02m | 8.00 | -- | -- | -- | 760.30 | -4.62 | -4.62 | 0.0163 | -0.9259 | 0.0206 | -- | -- | 3,456.25 | -580.66 | -376.60 | -- | -- | 41.99 | -- | -28,127.23 | -96,315.32 | -- | -97.39 | -- | -- | -- | -- | 11.07 | -- | -- | -- |
| Synlogic Inc | 3.37m | -57.28m | 21.39m | 6.00 | -- | 0.3963 | -- | 6.35 | -11.41 | -11.41 | 0.6581 | 4.64 | 0.0362 | -- | -- | 561,833.30 | -61.46 | -40.57 | -74.45 | -43.82 | -- | -- | -1,699.26 | -3,245.93 | -- | -- | 0.00009 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
| AIM ImmunoTech Inc | 202.00k | -28.96m | 21.63m | 26.00 | -- | 2.19 | -- | 107.07 | -0.595 | -0.595 | 0.0042 | 0.2084 | 0.0068 | -- | 0.1413 | 7,769.23 | -96.75 | -45.64 | -116.18 | -48.35 | 79.21 | -231.75 | -14,337.62 | -11,695.01 | -- | -- | 0.00 | -- | 43.26 | -11.26 | -48.94 | -- | 35.73 | -- |
| Biomx Inc | 0.00 | -26.17m | 22.09m | 58.00 | -- | 5.97 | -- | -- | -0.5433 | -0.5433 | 0.00 | 0.067 | 0.00 | -- | -- | 0.00 | -74.18 | -- | -101.74 | -- | -- | -- | -- | -- | -- | -21.95 | 0.7841 | -- | -- | -- | 7.59 | -- | -- | -- |
| Neurosense Therapeutics Ltd | 0.00 | -11.28m | 22.36m | 16.00 | -- | -- | -- | -- | -0.7625 | -0.7625 | 0.00 | -0.1219 | 0.00 | -- | -- | 0.00 | -207.24 | -- | -395.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.59 | -- | -- | -- |
| Inhibitor Therapeutics Inc | 0.00 | -3.03m | 22.36m | 3.00 | -- | 4.23 | -- | -- | -0.0176 | -0.0176 | 0.00 | 0.0307 | 0.00 | -- | -- | 0.00 | -28.92 | 27.48 | -30.91 | 32.70 | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | -125.39 | -- | -- | -- |
| Vincerx Pharma Inc | 0.00 | -40.16m | 22.40m | 42.00 | -- | 1.56 | -- | -- | -1.89 | -1.89 | 0.00 | 0.5242 | 0.00 | -- | -- | 0.00 | -103.63 | -- | -128.01 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 36.24 | -- | -- | -- |
Data as of May 07 2024. Currency figures normalised to Zivo Bioscience Inc's reporting currency: US Dollar USD
0.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Column Capital Advisors LLCas of 30 Sep 2023 | 2.00k | 0.07% |
| Bartlett & Co. Wealth Management LLCas of 31 Dec 2023 | 166.00 | 0.01% |
| Wells Fargo Advisors Financial Network LLCas of 31 Dec 2023 | 0.00 | 0.00% |
| PNC Bank, NA (Investment Management)as of 31 Dec 2023 | 0.00 | 0.00% |
| RBC Dominion Securities, Inc.as of 31 Dec 2023 | 0.00 | 0.00% |
| Tower Research Capital LLCas of 31 Dec 2023 | 0.00 | 0.00% |
| The Vanguard Group, Inc.as of 31 Jan 2024 | 0.00 | 0.00% |
| Wells Fargo Clearing Services LLCas of 31 Dec 2023 | 0.00 | 0.00% |
| Armistice Capital LLCas of 31 Dec 2023 | 0.00 | 0.00% |
| Schechter Investment Advisors LLCas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
